GSN
Gelsolin
Also known as: DKFZp313L0718, GELS_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P06396
- Gene
- GSN
- Ensembl
- ENSG00000148180
- Chromosome
- 9
- Canonical length
- 782 aa
- Protein class
- Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins
- Subcellular location
- Actin filaments
- Secretome location
- Secreted to blood
OverviewNCBI Gene
The protein encoded by this gene binds to the """"""""""""""""""""""""""""""""plus"""""""""""""""""""""""""""""""" ends of actin monomers and filaments to prevent monomer exchange. The encoded calcium-regulated protein functions in both assembly and disassembly of actin filaments. Defects in this gene are a cause of familial amyloidosis Finnish type (FAF). Multiple transcript variants encoding several different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
782 residues, UniProt reviewed canonical sequence.
>P06396|GSN
1 MAPHRPAPAL LCALSLALCA LSLPVRAATA SRGASQAGAP QGRVPEARPN SMVVEHPEFL
61 KAGKEPGLQI WRVEKFDLVP VPTNLYGDFF TGDAYVILKT VQLRNGNLQY DLHYWLGNEC
121 SQDESGAAAI FTVQLDDYLN GRAVQHREVQ GFESATFLGY FKSGLKYKKG GVASGFKHVV
181 PNEVVVQRLF QVKGRRVVRA TEVPVSWESF NNGDCFILDL GNNIHQWCGS NSNRYERLKA
241 TQVSKGIRDN ERSGRARVHV SEEGTEPEAM LQVLGPKPAL PAGTEDTAKE DAANRKLAKL
301 YKVSNGAGTM SVSLVADENP FAQGALKSED CFILDHGKDG KIFVWKGKQA NTEERKAALK
361 TASDFITKMD YPKQTQVSVL PEGGETPLFK QFFKNWRDPD QTDGLGLSYL SSHIANVERV
421 PFDAATLHTS TAMAAQHGMD DDGTGQKQIW RIEGSNKVPV DPATYGQFYG GDSYIILYNY
481 RHGGRQGQII YNWQGAQSTQ DEVAASAILT AQLDEELGGT PVQSRVVQGK EPAHLMSLFG
541 GKPMIIYKGG TSREGGQTAP ASTRLFQVRA NSAGATRAVE VLPKAGALNS NDAFVLKTPS
601 AAYLWVGTGA SEAEKTGAQE LLRVLRAQPV QVAEGSEPDG FWEALGGKAA YRTSPRLKDK
661 KMDAHPPRLF ACSNKIGRFV IEEVPGELMQ EDLATDDVML LDTWDQVFVW VGKDSQEEEK
721 TEALTSAKRY IETDPANRDR RTPITVVKQG FEPPSFVGWF LGWDDDYWSV DPLDRAMAEL
781 AALocalizationUniProt · AlphaFold · HPA
Whether an antibody against GSN can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 2,454 nTPM
Expression across tissuesHPA
Tissue
- heart muscle: 2,454 nTPM
- adipose tissue: 1,808 nTPM
- blood vessel: 1,257 nTPM
- breast: 1,237 nTPM
- urinary bladder: 954 nTPM
- colon: 797 nTPM
Single-cell type
- fibroblasts: 3,017 nCPM
- esophageal apical cells: 1,512 nCPM
- goblet cells: 1,203 nCPM
- vascular endothelial cells: 980 nCPM
- schwann cells: 881 nCPM
- megakaryocytes: 878 nCPM
Immune cell
- eosinophil: 1,140 nTPM
- myeloid DC: 346 nTPM
- neutrophil: 309 nTPM
- basophil: 304 nTPM
- plasmacytoid DC: 244 nTPM
- NK-cell: 219 nTPM
Brain region
- medulla oblongata: 741 nTPM
- white matter: 686 nTPM
- basal ganglia: 572 nTPM
- pons: 561 nTPM
- cerebellum: 533 nTPM
- midbrain: 513 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about GSN.
Disease | AllUniProt
Conditions GSN is implicated in, by any mechanism.
- Amyloidosis, hereditary systemic 4, Finnish type (AMYLD4) MIM:105120
Disease | GeneticClinVar
6 pathogenic / likely-pathogenic of 988 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Finnish type amyloidosis
- Inborn genetic diseases
Disease | ImmuneIEDB
Conditions an epitope on GSN was assayed in.
- rheumatoid arthritis B and T cell
ReferencesPubMed · IEDB
Publications for GSN from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
1 publication
Reference: B cellIEDB
1 publication
- Disordered Antigens and Epitope Overlap Between Anti-Citrullinated Protein Antibodies and Rheumatoid Factor in Rheumatoid Arthritis.
2020 · Arthritis Rheumatol · RCR 1.7 · 30 citations
Reference: T cellIEDB
1 publication
- Isolation of HLA-DR-naturally presented peptides identifies T-cell epitopes for rheumatoid arthritis.
2022 · Ann Rheum Dis · RCR 1.1 · 14 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. IEDB — curated epitope assays from the Immune Epitope Database (Vita et al., Nucleic Acids Research 2019). Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.84
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.96
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- actin filament capping
- actin filament depolymerization
- actin filament organization
- actin filament polymerization
- actin filament severing
- actin polymerization or depolymerization
- amyloid fibril formation
- barbed-end actin filament capping
- cardiac muscle cell contraction
- cell projection assembly
- cellular response to type II interferon
- central nervous system development
- cilium assembly
- hepatocyte apoptotic process
- host-mediated suppression of symbiont invasion
- phagocytosis, engulfment
- positive regulation of actin nucleation
- positive regulation of gene expression
- positive regulation of keratinocyte apoptotic process
- positive regulation of protein processing in phagocytic vesicle
- protein destabilization
- relaxation of cardiac muscle
- renal protein absorption
- response to muscle stretch
- striated muscle atrophy
- regulation of establishment of T cell polarity
- regulation of plasma membrane raft polarization
- regulation of receptor clustering
Molecular functions
- actin binding
- actin filament binding
- calcium ion binding
- myosin II binding
- phosphatidylinositol 3-kinase catalytic subunit binding
- phosphatidylinositol-4,5-bisphosphate binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of GSN in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GSN as an antibody target. Whether an autoantibody or antibody against GSN could matter depends on whether native GSN is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GSN is annotated as secreted, so native GSN circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label GSN as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...